News Summary: Smith & Nephew buys Healthpoint

Published



THE DEAL: British medical technology company Smith & Nephew PLC is buying Texas-based Healthpoint Biotherapeutics for $782 million.

THE TARGET: Healthpoint Biotherapeutics, founded in 1992, is a privately owned company that focuses on acute, chronic and burn-related wound care. The company, with 460 employees, will remain based in Fort Worth.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.